Bank of America’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$70.5M Buy
1,320,461
+1,059,860
+407% +$56.6M 0.01% 1264
2025
Q1
$10.5M Buy
260,601
+194,337
+293% +$7.87M ﹤0.01% 2627
2024
Q4
$1.84M Sell
66,264
-93,294
-58% -$2.6M ﹤0.01% 3813
2024
Q3
$4.58M Sell
159,558
-102,672
-39% -$2.95M ﹤0.01% 3249
2024
Q2
$6.15M Sell
262,230
-163,641
-38% -$3.84M ﹤0.01% 2950
2024
Q1
$10.8M Sell
425,871
-63,770
-13% -$1.61M ﹤0.01% 2492
2023
Q4
$11.4M Buy
489,641
+294,756
+151% +$6.88M ﹤0.01% 2288
2023
Q3
$9.86M Buy
194,885
+45,966
+31% +$2.32M ﹤0.01% 2309
2023
Q2
$6.95M Sell
148,919
-82,502
-36% -$3.85M ﹤0.01% 2602
2023
Q1
$8.85M Buy
231,421
+29,032
+14% +$1.11M ﹤0.01% 2520
2022
Q4
$11.1M Buy
202,389
+132,069
+188% +$7.24M ﹤0.01% 2206
2022
Q3
$2.39M Buy
70,320
+31,842
+83% +$1.08M ﹤0.01% 3493
2022
Q2
$363K Sell
38,478
-23,763
-38% -$224K ﹤0.01% 4941
2022
Q1
$883K Buy
62,241
+22,452
+56% +$319K ﹤0.01% 4711
2021
Q4
$842K Sell
39,789
-14,260
-26% -$302K ﹤0.01% 4717
2021
Q3
$1.21M Buy
54,049
+45,299
+518% +$1.01M ﹤0.01% 4191
2021
Q2
$217K Sell
8,750
-1,888
-18% -$46.8K ﹤0.01% 5278
2021
Q1
$308K Buy
10,638
+3,106
+41% +$89.9K ﹤0.01% 5092
2020
Q4
$194K Sell
7,532
-24,664
-77% -$635K ﹤0.01% 4899
2020
Q3
$991K Buy
32,196
+23,321
+263% +$718K ﹤0.01% 3704
2020
Q2
$221K Buy
8,875
+6,126
+223% +$153K ﹤0.01% 4637
2020
Q1
$58K Sell
2,749
-3,209
-54% -$67.7K ﹤0.01% 5208
2019
Q4
$132K Buy
5,958
+3,997
+204% +$88.6K ﹤0.01% 5057
2019
Q3
$46K Buy
+1,961
New +$46K ﹤0.01% 5512